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Abstract
 
Interleukin (IL)-18 has been well characterized as a costimulatory factor for the induction of IL-
 
12–mediated interferon (IFN)-
 
 
 
 production by T helper (Th)1 cells, but also can induce IL-4
production and thus facilitate the differentiation of Th2 cells. To determine the mechanisms by
which IL-18 might regulate these diametrically distinct immune responses, we have analyzed
the role of cytokines in the regulation of IL-18 receptor 
 
 
 
 chain (IL-18R
 
 
 
) expression. The
 
majority of peripheral CD4
 
 
 
 T cells constitutively expressed the IL-18R
 
 
 
. Upon antigen stim-
ulation in the presence of IL-12, marked enhancement of IL-18R
 
 
 
 expression was observed.
IL-12–mediated upregulation of IL-18R
 
 
 
 required IFN-
 
 
 
. Activated CD4
 
 
 
 T cells that ex-
pressed low levels of IL-18R
 
 
 
 could produce IFN-
 
 
 
 when stimulated with the combination of
IL-12 and IL-18, while CD4
 
 
 
 cells which expressed high levels of IL-18R
 
 
 
 could respond to
IL-18 alone. In contrast, T cell stimulation in the presence of IL-4 resulted in a downregulation
 
of IL-18R
 
 
 
 expression. Both IL-4
 
 
 
/
 
 
 
 and signal transducer and activator of transcription
(Stat)6
 
 
 
/
 
 
 
 T cells expressed higher levels of IL-18R
 
 
 
 after TCR stimulation. Furthermore, ac-
tivated T cells from Stat6
 
 
 
/
 
 
 
 mice produced more IFN-
 
 
 
 in response to IL-18 than wild-type
controls. Thus, positive/negative regulation of the IL-18R
 
 
 
 by the major inductive cytokines
(IL-12 and IL-4) determines the capacity of IL-18 to polarize an immune response.
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–inducing factor • IL-12 • IL-1R–related protein • Stat • IFN-
 
 
 
Introduction
 
IL-18 is an 18-kD cytokine originally described as IFN-
 
 
 
–inducing factor for its ability to augment IFN-
 
 
 
 pro-
duction by activated T cells (1). Subsequently, IL-18 has
been regarded as a proinflammatory cytokine that can syn-
ergize with IL-12 to increase IFN-
 
 
 
 production, NK cell
cytotoxicity, and Th1 responses (2–5). While IL-18
clearly enhances Th1 responses, it is less clear whether IL-
18 is capable of initiating Th1 differentiation in the ab-
sence of IL-12 (6–10). Although a majority of published
reports link IL-18 with Th1-associated functions, IL-18
has recently been shown to augment Th2 responses (11–
14). Administration of IL-18 to mice led to an increase in
IL-4 production and elevated serum IgE. The mechanisms
whereby IL-18 can influence both Th1 and Th2 responses
are unclear at this time.
The IL-18R complex is composed of two known
 
chains, IL-18 receptor 
 
 
 
 chain (IL-18R
 
 
 
)
 
* 
 
and IL-18R
 
 
 
(15–20). IL-18R
 
 
 
 (IL-1R5) was originally described as IL-1
 
receptor-related protein (IL-1Rrp) because of its homol-
ogy with the IL-1/Toll receptor family and is the extracel-
lular binding domain of the IL-18R complex. IL-18R
 
 
 
(also known as IL-18RAcPL or IL-1R7) is the signal trans-
ducing chain of the IL-18R complex and is also a member
of the IL-1R family. It has been widely believed that the
IL-18R
 
 
 
 is not expressed on naive T cells, but is induced
during differentiation of Th1, but not Th2, cells. Here, we
have used a recently developed polyclonal antibody to IL-
18R
 
 
 
 to investigate regulation of its expression on differ-
 
entiating CD4
 
 
 
 T cells. In contrast to previous studies, we
demonstrate that resting peripheral CD4
 
 
 
 and CD8
 
 
 
 T
 
Address correspondence to Ethan M. Shevach, National Institutes of
Health, Bldg. 10, Rm. 11N315, Bethesda, MD 20892. Phone: 301-496-
6449; Fax: 301-496-0222; E-mail: ems1@mail.nih.gov
 
*
 
Abbreviations used in this paper:
 
 IL-18R
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cells express IL-18R
 
 
 
. Although it has been proposed that
IL-12 alone may upregulate expression of the IL-18R
 
 
 
,
culture of naive CD4
 
 
 
 T cells in IL-12 or IL-18 alone had
no effect on IL-18R
 
 
 
 expression. However, activation of
T cells via the TCR in the presence of IL-12, but not IL-18,
resulted in marked upregulation of IL-18R
 
 
 
 expression.
The combination of IL-18 and IL-12 further enhanced
IL-18R
 
 
 
 expression during TCR activation. Although
IFN-
 
 
 
 did not directly regulate IL-18R
 
 
 
 expression,
IL-12–mediated upregulation of IL-18R
 
 
 
 was not ob-
served in the absence of IFN-
 
 
 
. After activation in the
presence of IL-12, the capacity of CD4
 
 
 
 T cells to produce
IFN-
 
 
 
 in response to IL-18 alone correlated with their ex-
pression of high levels of the IL-18R
 
 
 
. In sharp contrast,
the combination of TCR ligation and IL-4 led to a marked
downregulation of IL-18R
 
 
 
 on unprimed CD4
 
 
 
 T cells.
The downregulatory effects of IL-4 on IL-18R
 
 
 
 were
completely dependent on expression of signal transducer
and activator of transcription (Stat)6. Collectively, these re-
sults demonstrate that IL-18R
 
 
 
 expression is finely regu-
lated during the course of CD4
 
 
 
 T cell differentiation
along either the Th1 or Th2 pathways. They are most con-
sistent with a model in which IL-12/IFN-
 
 
 
 play a critical
function in upregulation of IL-18R
 
 
 
 expression during
differentiation along the Th1 pathway, while IL-4 plays a
downregulatory role on IL-18R
 
 
 
 during Th2 differentia-
tion. These data are critical to furthering our understanding
of the proposed dual role of IL-18 as a differentiation factor
for both Th1 and Th2 responses as well as its possible ther-
apeutic use as an adjuvant.
 
Materials and Methods
 
Animals.
 
Female C57BL/6, C57BL/6 IFN-
 
 
 
 
 
/
 
 
 
, C57BL/6
IL-4
 
 
 
/
 
 
 
 mice, and 5CC7 B10.A/Ai recombination activating
gene 
 
(
 
RAG)-2
 
 
 
/
 
 
 
 mice expressing a TCR transgene specific for
cytochrome C were obtained from Taconic Farms and used at
4–8 wk of age. Female BALB/c and Stat6
 
 
 
/
 
  
 
(C129S2-Stat6)
mice were obtained from Jackson ImmunoResearch Laboratories.
All animals were housed under specific pathogen-free conditions
and provided food and water ad libitum. Animals were main-
tained according to National Institutes of Health Animal Care
Guidelines.
 
Cell Lines.
 
Short-term polarized T cell lines were established
as follows: CD4
 
 
 
 T cells were isolated from lymph nodes of
5CC7 RAG-2
 
 
 
/
 
 
 
 mice by negative selection using FITC-labeled
anti-B220, anti-CD8, and anti–I-A
 
k
 
, followed by anti-FITC
magnetic separation. Purity of CD4
 
 
 
 population was confirmed
by FACS
 
®
 
 analysis. CD4
 
 
 
 T cells (10
 
5 
 
cells per milliliter) were
stimulated in vitro for 4–5 d with T cell–depleted, irradiated
B10.A APCs (10
 
6
 
 cells per milliliter) and 1 
 
 
 
M cytochrome C
peptide in IL-2–supplemented media containing 10% fetal bovine
serum, 
 
L
 
-glutamine, antibiotics, and 
 
 
 
-mercaptoethanol. To es-
tablish Th1 lines, IL-12 (10 ng/ml; R&D Systems) and anti–IL-4
(10 
 
 
 
g/ml 11B11) were added to cultures. For Th2 lines, IL-4
(1,000 U/ml), anti–IL-12 (10 
 
 
 
g/ml C17.8), and anti–IFN-
 
 
 
 (10
 
 
 
g/ml XMG 1.2) were added. Th “null” cells were established
by the addition of anti–IL-12, anti–IL-4, and anti–IFN-
 
 
 
 anti-
bodies. After 4–5 d, cells were washed and resuspended in fresh
IL-2 media for an additional 48 h (21).
 
In some experiments, splenic CD4
 
 
 
 T cells from wild-type
C57BL/6 or IFN-
 
 
 
 
 
/
 
 
 
 mice were cultured (4
 
   
 
10
 
6
 
 cells per
milliliter) with plate-bound anti-CD3 (5 
 
 
 
g/ml 2C11; BD
PharMingen) and IL-2 (with or without rIL-12, rIL-18, rIL-4,
rIL-10, rhTGF-
 
 
 
) for 48 h. Cells were washed, then resuspended
in fresh IL-2 media (with or without fresh cytokine added) for an
additional 48 h before FACS
 
®
 
 analysis.
 
Flow Cytometry.
 
Cells were washed twice in PBS, resus-
pended in PBS, and placed (1–2
 
   
 
10
 
6
 
 cells) into individual wells
of a 96-well V-bottomed Costar plate. The cells were first incu-
bated for 5 min at 4
 
 
 
C with 1 
 
 
 
g of rat anti–mouse CD16/CD32
(Fc block; BD PharMingen) to block nonspecific binding of goat
Ig/anti–IL-18R
 
 
 
 antibody to Fc receptors. Cells were then incu-
bated with either 1 
 
 
 
g of goat IgG or 1  g of goat anti-murine
IL-18R  (R&D Systems) diluted in PBS containing 5% normal
mouse serum (PBS-NMS). Anti–IL-18R  is an affinity-purified,
polyclonal goat-specific IgG antibody that recognizes the extra-
cellular domain (peptide 19–326) of recombinant murine IL-
18R . Cells were incubated with the respective antibody for 30
min, 4 C, washed two times with PBS, incubated in PBS-NMS
for 10 min, and then stained with SP-biotinylated mouse anti–
goat IgG (H plus L) diluted in PBS-NMS (Jackson ImmunoRe-
search Laboratories) for 20 min. Cells were subsequently washed
two times in PBS and then resuspended in streptavidin-PE (BD
PharMingen) diluted in PBS. After a 10-min incubation at 4 C,
FITC-labeled anti-CD4 (BD PharMingen) was added directly to
wells for an additional 20-min incubation at 4 C. Cells were
again washed two times in PBS and resuspended in PBS. 7-AAD
was added immediately before FACS® analysis to exclude dead
cells from analysis. Analysis was performed using CELLQuest™
software (Becton Dickinson).
Data are presented as the difference ( ) between the mean
fluorescence intensity (MFI) of the positive stain (anti–IL-18R )
and the MFI of the negative control (goat Ig).
Cytokine Assays. T cells that had been primed in vitro for
4–7 d under various polarizing conditions were resuspended in
fresh IL-2 medium. Cells (106 cells per milliliter) were cultured in
24-well plates for 48 h with 10 ng/ml IL-12, 30 ng/ml IL-18, or
both. Cell-free supernatants were collected and levels of IFN- 
determined by ELISA (R&D Systems). Alternatively, primed cells
were restimulated with either immobilized anti-CD3 (5  g/ml
2C11; BD PharMingen) or IL-12 and IL-18 (as above) for 6–8 h,
and monensin was added for the final 4 h of culture. Cells were
harvested, permeabilized with saponin/PBS buffer, then stained
for intracellular IFN-  and IL-4.
Results
Naive T Cells Express the IL-18R . In contrast to pre-
vious studies which only detected the IL-18R  on fully
differentiated Th1 cells (22), a majority (82   2%) of both
CD4  and CD8  splenic T cells from C57BL/6 mice were
reactive by FACS® analysis with the polyclonal antibody to
recombinant IL-18R  (Fig. 1, A and C). In multiple ex-
periments (n   5) of this type the  MFI of IL-18R  ex-
pression on freshly explanted CD4  T cells was 143   11.
CD4  and CD8  T cells in lymph node expressed levels of
IL-18R  similar to that seen in spleen (data not shown).
We also detected high levels of IL-18R  on mature CD4 
and CD8  single positive T cells in the thymus, while
CD4 CD8  double positive thymocytes expressed rela-145 Smeltz et al.
tively low levels (data not shown). Thus, expression of the
IL-18R  appears to be acquired during the process of T
cell differentiation in the thymus. Constitutive expression
of the IL-18R  was independent of either IL-12 or IFN- 
as the level of expression of the IL-18R  on CD4  cells
from IL-12 /  or IFN-  /  mice was identical to CD4  T
cells from wild-type mice (data not shown). Analysis of
other cell types revealed low levels of IL-18R  expression
on B220  splenic B cells (Fig. 1 D), while the highest level
of IL-18R  expression was found on NK1.1  cells (Fig. 1
E). We consistently identified a small population ( 6–10%)
of splenic CD4  cells that expressed high levels of the IL-
18R  (Fig. 1 A, M2, MFI 1,072   286). This IL-18R hi
population was absent in the spleens of 5CC7 TCR trans-
genic mice on a RAG-2 /  background (Fig. 1 B, arrow),
suggesting the CD4  IL-18R hi population in the former
could be a population of previously activated/memory T
cells or CD4 NK1.1  T cells. Further analyses revealed the
majority ( 90%) of CD4  IL-18R hi cells are NK1.1 
and express markers typically associated with memory/acti-
vated T cells (data not shown). Thus, two distinct levels of
IL-18R  expression (IL-18R int and IL-18R hi) can be
detected on CD4  T cells in spleens from normal animals.
Stimulation with IL-12 or IL-18 Alone Does Not Lead to
Upregulation of IL-18R  on CD4  IL-18R int T Cells.
Previous reports have suggested that IL-12 in the absence
of TCR stimulation was capable of inducing IL-18R  ex-
pression, thus enabling IL-18 to synergize with IL-12 to
enhance IFN-  production (23). To evaluate the effects of
cytokines on IL-18R  expression, we cultured spleen cells
from normal C57BL/6 mice for 96 h in IL-2–containing
media alone or in IL-2–containing media supplemented
with either IL-12 or IL-18. Preliminary studies demon-
strated that IL-2 was required to maintain adequate viabil-
ity of the cells. Culture with IL-2 alone led to a decrease in
IL-18R  expression on CD4  IL-18R int cells (Fig. 1 A,
M1, MFI 143   21; and Fig. 2 A, M1, MFI 94   15), but
did not modify the level of expression of IL-18R  on the
subpopulation of IL-18R hi cells (Fig. 1 A, M2, MFI 1,088  
109; and Fig. 2 A, M2, MFI 1,072   286). However, it
should be noted that culture in IL-2 alone did result in a
marked increase in the percentage of the IL-18R hi popu-
lation from 6–10% to  20–40% of CD4  T cells during
the 96-h culture (Figs. 1 A and 2 A). This increase presum-
ably reflects the preferential expansion of previously acti-
vated/memory T cells in the presence of IL-2. Slight
upregulation of IL-18R  expression on the CD4 
IL-18R int cells was observed in the presence of IL-12
(MFI 102   12), but not IL-18 (Fig. 2, B–D, M1, MFI
88   13). In striking contrast, the minor population of
CD4  IL-18R hi cells upregulated IL-18R  expression in
response to IL-12 (Fig. 2 B, M2, MFI 2,425   1,074), but
not IL-18 (Fig. 2 C, M2, MFI 1,029   171). Thus, the pri-
mary effects of IL-12 on freshly explanted CD4  T cells
from normal animals appear to be via upregulation of the
IL-18R  on the minor population of CD4  T cells that al-
ready express high levels of this receptor and which appear
to be memory/activated T cells.
IL-12 in Concert with TCR Stimulation Induces Upregula-
tion of IL-18R  Expression on CD4  T Cells. To exam-
ine the effects of TCR stimulation on IL-18R  expression,
CD4  T cells from naive C57BL/6 mice were stimulated
for 2 d with immobilized anti-CD3 in IL-2–containing
media, with or without IL-12/IL-18. After 2 d in culture,
the cells were harvested, washed, and placed into fresh IL-2
media with fresh cytokines for an additional 2 d. This two-
step culture system was used because significant apoptosis
was observed when T cells were cultured for 4 d on plate-
bound anti-CD3. IL-18R  expression was detected on
CD4  T cells stimulated with anti-CD3 and IL-2, but the
Figure 1. Expression of IL-18R  on cells from naive mice: splenic
CD4  (A) and CD8  (C) T cells from C57BL/6 mice, CD4  T cells
from 5CC7 TCR transgenic mice on RAG-2 /  background (B), B220 
cells (D), and NK1.1  cells (E) from spleens of C57BL/6 mice. Spleen
cells were pooled from naive mice and analyzed for IL-18R  expression
by FACS®. Analysis was gated on 7-AAD  cells only (i.e. viable cells).
Numbers in parentheses refer to the difference ( ) between the MFI of
the positive stain and the MFI of the isotype (negative) stain.146 Regulation of IL-18 Receptor Expression
level of expression was consistently less than that observed
on freshly explanted CD4  T cells (compare Fig. 3 A with
Fig. 1 A) and CD4  T cells cultured in IL-2 alone (com-
pare Fig. 2 A, M1 with Figs. 3 A and 1 A). However, the
addition of IL-12 to anti–CD3-stimulated cultures led to
marked upregulation of IL-18R  expression (Fig. 3 B),
while the addition of IL-18 alone did not result in en-
hanced IL-18R  expression (Fig. 3 C). IL-18 did synergize
with IL-12 to enhance IL-18R  expression (Fig. 3 D).
Resting CD4  T cells failed to produce IFN-  on expo-
sure to IL-12, IL-18, or the combination of IL-12/IL-18
(data not shown). However, after anti-CD3 induced T cell
activation, large amounts of IFN-  were produced in re-
sponse to IL-12/IL-18 irrespective of the priming condi-
tions (Fig. 3, E–H). More importantly, the upregulation of
IL-18R  expression seen when T cells were cultured with
IL-12 correlated with the ability of IL-18 to induce IFN- 
production in the absence of IL-12 (Fig. 3, F and H). T
cells primed with IL-2 (Fig. 3 E) or IL-18 (Fig. 3 G) did not
produce detectable IFN-  when cultured with IL-18 alone.
Regulation of IL-18R  Expression by IFN- . As IFN- 
is induced by IL-12, it was possible that IL-12–mediated
upregulation of the IL-18R  was secondary to IFN- 
production. To test this, we stimulated T cells from IFN-
  /  mice with anti-CD3 and IL-2. After 4 d of culture,
CD4  T cells from IFN-  /  mice expressed levels of IL-
18R  that were similar to wild-type C57BL/6 mice (Fig.
4, A and B). Therefore, the mere absence of IFN-  does
not lead to downregulation of IL-18R  expression. How-
ever, IL-12–dependent upregulation of IL-18R  expres-
sion was severely impaired in the absence of IFN- . A ma-
jority of CD4  T cells from IFN-  /  mice failed to
upregulate IL-18R  expression when cultured with anti-
CD3 and IL-12 (M1; Fig. 4, C and D). Addition of IFN- 
to these cultures restored IL-12–driven upregulation of
Figure 2. Stimulation with IL-12 or
IL-18 alone does not lead to upregula-
tion of IL-18R  expression on CD4 
IL-18R int cells. Spleen cells from
C57BL/6 mice were cultured for 96 h
in IL-2 media (A) supplemented with 20
ng/ml IL-12 (B), 20 ng/ml IL-18 (C),
or both IL-12 and IL-18 (D). Cells were
subsequently harvested and analyzed for
IL-18R  expression by FACS®.
Figure 3.  IL-12 in concert with TCR stimulation results in upregula-
tion of IL-18R  expression on CD4  T cells. CD4  T cells from
C57BL/6 mice were stimulated with plate-bound anti-CD3 for 2 d in
IL-2 alone (A and E), or with IL-2 and IL-12 (B and F), IL-18 (C and G),
or IL-12 and IL-18 (D and H). Cells were then washed and placed into
fresh IL-2 media with or without cytokines for an additional 2 d. Cells
were then harvested and stained for IL-18R  expression (A–D). Alterna-
tively, the cells were restimulated with either IL-12, IL-18, or both IL-12
and IL-18 for 48 h and supernatants tested for IFN-  production (E–H).147 Smeltz et al.
IL-18R ; however, IFN-  itself did not enhance IL-18R 
expression in the absence of IL-12 (M1; Fig. 4, E and F).
These data demonstrate that IFN-  is required for IL-12–
mediated upregulation of IL-18R  expression and most
likely functions by inducing/maintaining IL-12R 2 ex-
pression. However, we consistently observed a minor pop-
ulation of T cells that could upregulate their IL-18R 
in an IL-12–dependent but IFN- –independent fashion
(M2; Fig. 4, B and D–F). We suspect these are memory T
cells, based on our observations that memory cells can up-
regulate their IL-18R  expression in response to IL-12
alone (Fig. 2, A–D).
IL-4 in Concert with TCR Stimulation Induces Downregula-
tion of IL-18R . While previous studies have focused on
IL-12 and its ability to augment IL-18 responses, very lit-
tle is known about the cytokines which may negatively
regulate IL-18R  expression. Therefore, we stimulated
C57BL/6 CD4  T cells with anti-CD3/IL-2 in the pres-
ence of IL-4, IL-10, or TGF- . IL-4 markedly enhanced
the downregulation of IL-18R  expression observed when
T cells were cultured with anti-CD3 and IL-2 (Fig. 5, A,
B, I, and K). While the addition of IL-10 had no effect
(Fig. 5 C), the addition of TGF-  augmented IL-18R 
expression (Fig. 5 D). Although T cells primed in the pres-
ence of IL-4 or IL-10 expressed detectable levels of the IL-
18R , they failed to secrete IFN-  in response to IL-18
alone (Fig. 5, F and G). However, these cells were capable
of producing significant quantities of IFN-  when cultured
with both IL-12 and IL-18 (Fig. 5, F–H). Because these
studies were performed without concomitant neutraliza-
tion of IL-12 and/or IFN- , it is possible that the inability
of IL-4 to completely inhibit IFN-  induction by IL-12
and IL-18 is due to endogenous IL-12/IFN- .
Because the addition of exogenous IL-4 was capable of
downregulating IL-18R , we suspected that endogenous
IL-4 was partially responsible for the downregulation of IL-
18R  observed with anti-CD3 stimulation in the absence
of any added cytokine (Fig. 5 A). To test this hypothe-
sis, we stimulated T cells from IL-4 /  mice and measured
IL-18R  expression. When compared with wild-type
C57BL/6 mice, IL-4 /  T cells expressed significantly
higher levels of IL-18R  after anti-CD3 stimulation (Fig.
5, I and J). Levels of IL-18R  expression before stimula-
tion were comparable for both C57BL/6 and IL-4 /  mice
(data not shown). However, the addition of exogenous
IL-4 resulted in a downregulation of IL-18R  that was
comparable to that seen with wild-type cells (Fig. 5, K and
L). These results confirm a critical role for IL-4 in down-
regulation of IL-18R .
Requirement for Stat6 in Regulation of IL-18R  Expression/
Function on CD4  T Cells. Because IL-4 signals mainly
via Stat6, we determined if Stat6 signaling was required for
IL-4–induced downregulation of IL-18R  after T cell acti-
vation. After stimulation with anti-CD3 and IL-2, CD4  T
cells from Stat6 /  mice expressed higher levels of IL-
18R  (  MFI    208) compared with wild-type T cells
( MFI   93; Fig. 6, A and D). This suggests that endoge-
nous Stat6 signaling partially contributes to anti-CD3–
induced downregulation of IL-18R , which is consistent
with the results obtained with IL-4 /  mice (Fig. 5, I–K).
In contrast to the downregulatory effects of IL-4 seen with
wild-type T cells (Fig. 6 B), the addition of IL-4 to cultures
of CD4  T cells from Stat6 /  mice had no effect on IL-
18R  expression (Fig. 6 E) indicating that Stat6 is required
for IL-4–mediated downregulation of IL-18R  expression.
Interestingly, the ability of IL-12 to augment IL-18R  ex-
Figure 4. IL-12–mediated enhancement of IL-18R  expression is IFN-  dependent. Spleen cells from wild-type C57BL/6 (A and C) and IFN-  /  (B–F)
mice were stimulated for 2 d with plate-bound anti-CD3 and IL-2 (A and B) alone, or with IL-2 and IL-12 (C and D), IFN-  (E), or IL-12 and IFN-  (F).
After 2 d, cells were washed and placed into fresh IL-2 media with fresh cytokine for an additional 2 d. Cells were then stained for IL-18R  expression.148 Regulation of IL-18 Receptor Expression
pression was significantly enhanced in the absence of Stat6
(Fig. 6, C and F). To correlate the differences in receptor
expression with the ability of IL-18 to induce IFN-  pro-
duction, anti-CD3–primed T cells from both BALB/c and
Stat6 /  mice were restimulated with either immobilized
anti-CD3 or cytokine and subsequently stained for intra-
cellular IFN- . T cells from Stat6 / mice produced more
IFN-  in response to anti-CD3 stimulation, as well as the
combination of IL-12 and IL-18 (Fig. 6, G–K). Impor-
tantly, IL-18–induced IFN-  production was significantly
enhanced in Stat6 /  mice (13 vs. 7%, Fig. 6 J), which is
consistent with the higher levels of IL-18R  expression
observed on Stat6 /  mice (Fig. 6 D). These results suggest
that IL-4 and Stat6 are critical regulators of both IL-18R 
expression and IL-18 responsiveness.
CD4  T Cells Primed under Th1 Conditions Upregulate IL-
18R . Since we found that all naive CD4  T cells ex-
pressed the IL-18R , it was of interest to examine the ki-
netics of regulation of expression during the differentiation
of naive CD4  T cells into Th1 and Th2 cells. For this
purpose, we used T cells from 5CC7 transgenic mice on
the RAG-2 /  background to minimize the number of
previously activated T cells in the starting population. Th1
cells were generated by culturing purified CD4  T cells
with APCs, antigen, IL-12, and anti–IL-4 as described pre-
viously (21). After 1 wk in culture, the cells were restimu-
lated with antigen and APCs. Intracellular cytokine staining
revealed that 45% of 1-wk (1 ) Th1 cells expressed IFN- 
(Fig. 7 A). No IL-4 could be detected in this population.
1-wk Th1 cells expressed high levels of IL-18R  before
restimulation (Fig. 7 D), but these levels increased upon
stimulation with APCs and antigen (Fig. 7 G). Upon re-
stimulation, Th1 cells secreted large amounts of IFN-  after
culture with IL-12 and IL-18, but also secreted significant
amounts of IFN-  when cultured with IL-18 alone (Fig. 7
J). The null cells were generated by priming with peptide,
APCs, and IL-2 in the presence of anti–IL-4, anti–IL-12,
and anti–IFN-  antibodies. Although these cells prolifer-
ated vigorously when restimulated with peptide and APCs,
they failed to differentiate into Th1 or Th2 cells as judged
by the lack of intracellular staining for IFN-  or IL-4 (Fig.
7 B). The level of IL-18R  on Th null cells after 1 wk of
culture and restimulation was similar to that seen on un-
stimulated CD4  T cells (Figs. 7, E and H, and 1 A). Thus,
neither IL-12 nor IFN-  is required for maintenance of the
basal level of IL-18R  expression during the 1-wk priming
period. These results are consistent with those obtained
with anti-CD3–stimulated T cells from IFN-  /  (Fig. 4)
and IL-12 /  (data not shown) mice. Interestingly, Th null
cells failed to produce IFN-  when restimulated with IL-
12 or IL-18 alone, but did respond to the combination of
IL-12 and IL-18 (Fig. 7 K).
CD4  T Cells Primed under Th2 Conditions Rapidly Down-
regulate IL-18R  Expression. The results obtained with
Th1 cells (Fig. 7) are consistent with the observation that
terminally differentiated Th1 cells express high levels of IL-
18R . To understand the dynamics of IL-18R  during
Th2 differentiation, TCR transgenic CD4  T cells were
cultured in the presence of antigen, APCs, IL-4, anti–IL-
12, and anti–IFN- . After 1 wk of priming, 22% of the
cells expressed intracellular IL-4, but not IFN- , when re-
stimulated with antigen and APCs (Fig. 7 C). However,
expression of the IL-18R  was markedly downregulated
after 1 wk of priming under Th2 conditions (Fig. 7, F and
I). More impressively, Th2 cells failed to secrete any de-
tectable IFN-  when cultured with IL-12, IL-18, or both
IL-12 and IL-18 (Fig. 7 L). Thus, signaling via IL-12 and
IL-18 receptors is extinguished even after 1 wk of priming
under Th2 conditions.
Figure 5. IL-4 induces downregulation of IL-18R  in response to
stimulation with anti-CD3. CD4  T cells from wild-type C57BL/6 (A–I
and K) or IL-4 /  (J and L) mice were stimulated for 2 d with plate-
bound anti-CD3 and IL-2 alone (A, E, I, and J), or with IL-2 and IL-4
(B, F, K, and L), IL-10 (C and G), or TGF-  (D and H). The cells were
then washed and placed into fresh IL-2 media with fresh cytokine for an
additional 2 d. Cells were then stained for IL-18R  expression (A–D and
I–L). Alternatively, cells were restimulated with IL-12, IL-18, or both IL-
12 and IL-18, and supernatants were tested for IFN-  production.149 Smeltz et al.
Discussion
IL-18 has now been well characterized as a costimulatory
factor for IL-12–mediated Th1 differentiation. IL-18 may
mediate its effects directly by augmentation of IFN-  pro-
duction (6, 10, 23, 24) or by enhancement of the expres-
sion of the IL-12R complex, thereby potentiating the ef-
fects of IL-12 (25). While many studies have focused
attention on the regulation of the IL-12R during Th cell
differentiation, fewer have focused on regulation of the IL-
18R (24, 26–29). It has been widely assumed that the
IL-18R  is expressed only after T cell activation as the IL-
18R  could readily be detected on fully differentiated mu-
rine Th1 cells, but not on Th2 cells, either at the mRNA
level or at the cell surface (22–24, 26). We have used a
polyclonal antibody prepared against residues 19–346 of the
extracellular domain of the IL-18R  and were readily able
to detect IL-18R  on almost all CD4  and CD8  T cells.
It is highly likely that our ability to detect the IL-18R  on
naive cells is related to both the specificity of the antibody
we have used as well as to our staining protocol.
Although the IL-18R  was expressed at relatively uni-
form levels on the majority of CD4  T cells, we detected a
subpopulation of unstimulated CD4  T cells that expressed
 5–10-fold higher levels of receptor than the majority of
the CD4  population. These cells appeared to be activated/
memory T cells based on their coexpression of other mark-
ers (CD62Llow, CD44hi, and data not shown). In contrast to
the majority of CD4  IL-18R int cells, the CD4  IL-
18R hi cells upregulated expression of the IL-18R  on
culture with IL-12 alone. It is very likely that the effects of
IL-12 alone on IL-18R  that have been reported by others
(23) are secondary to stimulation of this memory T cell
population. Indeed, in our hands fully differentiated Th1
clones will also upregulate IL-18R  in response to IL-12
and produce IFN-  in the absence of TCR ligation. There-
fore, it is unlikely that truly naive cells can respond to IL-12
by upregulating the IL-18R , especially since these cells do
not express the IL-12R 2 subunit which is required for IL-
12 signaling. We have not yet studied the regulation of the
IL-18R  on CD8  T cells in response to IL-12 and it also
remains possible that the IL-18R  is differentially regulated
on CD8  T cells. In the studies of Yoshimoto et al. (23), no
effort was made to separate CD4  cells and CD8  cells.
Short-term culture of CD4  T cells in IL-2 alone led to
downregulation of IL-18R  on the CD4   IL-18R int
population, and this downregulatory effect was further po-
tentiated by stimulation via the TCR. These data are con-
sistent with a previous report showing anti-CD3–triggered
downregulation of IL-18R  expression (23) and with the
observations of Ahn et al. (30) that culture of a Th1 clone
Figure 6. Stat6 is required for IL-4–mediated downregulation of IL-
18R  expression and IL-18–induced IFN- . CD4  T cells from wild-
type BALB/c (A–C and G–K) and Stat6 /  (D–F and G–K) mice were
stimulated for two d with plate-bound anti-CD3 and IL-2 alone (A and
D), or with IL-2 and IL-4 (B and E) or IL-12 (C and F). The cells were
then washed and placed into fresh IL-2 media with fresh cytokine for an
additional 2 d. Cells were then stained for IL-18R  expression. Alterna-
tively, cells from BALB/c or Stat6 /  mice were primed for 7 d with
anti-CD3 and IL-2, then restimulated with either anti-CD3 (G), IL-2
(H), IL-12 (I and K), or IL-18 (J and K). Cells were stained for intracellu-
lar IFN-  and IL-4.150 Regulation of IL-18 Receptor Expression
with IL-2 alone also led to downregulation of IL-18R 
expression. In contrast to the findings of Yoshimoto et al.
(23), we found that culture of CD4  T cells with the com-
bination of anti-CD3 and IL-12 led to a pronounced in-
crease in IL-18R  expression on the CD4  IL-18R int
population. A possible difference between the results pre-
sented here and those of others is that in our 4-d culture
system with anti-CD3 and cytokines, T cells were cultured
with immobilized anti-CD3 for only the first 2 d to reduce
cell death as the result of repeated stimulation via the TCR.
Culture of CD4  T cells with anti-CD3 and IL-18 failed
to induce upregulation of the IL-18R . However, IL-18
could synergize with IL-12 to induce IL-18R  upregula-
tion in the presence of anti-CD3. Collectively, these results
are most consistent with a model in which IL-12 dictates
IL-18 responsiveness in CD4  T cells. Further evidence of
this is supported by the observation that the ability of IL-12
to upregulate IL-18R  expression is abrogated in Stat4 / 
mice (data not shown).
The capacity of IL-12 to induce upregulation of the IL-
18R  was completely IFN-  dependent, as T cells from
IFN-  /  mice did not upregulate their IL-18R  when
stimulated with anti-CD3 and IL-12. Although reconstitu-
tion of these cultures with IFN-  restored IL-18R  ex-
pression, IFN-  itself did not enhance IL-18R  expression
in the absence of IL-12. Thus, IFN-  increases T cell re-
sponsiveness to IL-12 mostly likely via its effects on induc-
tion/maintenance of expression of the IL-12R 2 chain.
The detection of IL-18R  on resting CD4  T cells
prompted us to examine the factors responsible for the ab-
sence of the IL-18R  on Th2 clones. We have demon-
strated that IL-4 rapidly downregulates the expression of
the IL-18R  during short-term stimulation of naive CD4 
T cells with anti-CD3. When CD4  T cells were primed
under Th2 conditions, marked downregulation was seen
after 1 wk of culture and after 3 wk of culture under Th2
conditions, there was no detectable IL-18R  expression
(data not shown). There was no observable downregulation
of IL-18R  when resting T cells were cultured with IL-4
(data not shown) in the absence of TCR stimulation, sug-
gesting that TCR-mediated signals are also required. The
effect of IL-4 on IL-18R  expression was even more dra-
Figure 7. Regulation of IL-18R  expression during
Th1/Th2 differentiation. CD4  T cells from 5CC7 trans-
genic mice were primed with irradiated APCs and cyto-
chrome C under Th1, Th null, or Th2 conditions. After 1
wk in culture, T cells were rechallenged for 6 h with PMA
and ionomycin and then stained for intracellular IFN- 
and IL-4 to confirm polarization of T cells into Th1 (A),
Th null (B), and Th-2 (C) phenotypes. Alternatively, T
cells were rechallenged for 2 d with APCs and antigen, but
in the absence of cytokines. Cells were analyzed for IL-
18R  expression both before (D–F) and after (G–I) re-
challenge. Also, Th1 (J), Th null (K), or Th2 (L) cells were
restimulated with the indicated cytokine and levels of
IFN-  determined by ELISA.151 Smeltz et al.
matic when T cells from IL-4 /  mice were used. IL-4 / 
T cells expressed higher levels of IL-18R  after the 4-d
culture when compared with wild-type cells; however, the
addition of exogenous IL-4 resulted in downregulation of
IL-18R  to levels similar to wild-type. This is consistent
with the notion that endogenous IL-4 contributes to IL-
18R  downregulation during anti-CD3 stimulation. Fur-
ther support for the role of IL-4 in negative regulation of
IL-18R  is that Stat6 /  T cells, which are impaired in
their ability to respond to IL-4, also express higher levels of
IL-18R  after T cell activation. In addition, the ability of
IL-12 to upregulate IL-18R  is enhanced in Stat6 /  T
cells. Surprisingly, the addition of TGF-  to either anti-
CD3 or antigen-primed cultures led to an increase in IL-
18R  expression. TGF-  has been shown by others to in-
hibit IL-4 production (31), and we hypothesize that the
inhibition of IL-4 production by TGF-  is responsible for
the observed increase in IL-18R  expression.
In addition to examining the cytokine requirements for
expression of the IL-18R  during Th1/Th2 differentia-
tion, we have also examined their effects on the induction
of both IL-12 and IL-18 responsiveness. Restimulation of
CD4  T cells that had been cultured for 4 d with anti-
CD3, IL-2, and the combination of IL-12 and IL-18, but
not either cytokine alone, resulted in production of large
amounts of IFN- . More importantly, when CD4  T cells
were cultured for 4 d with anti-CD3 and IL-12, they pro-
duced significant amounts of IFN-  when restimulated
with either IL-12 or IL-18 alone. Identical results were ob-
served with 1-wk Th1 cells. The capacity to respond to IL-
18 alone correlated with enhanced level of cell surface IL-
18R  expression. Although CD4  T cells cultured with
anti-CD3 and IL-4 for 4 d retained their capacity to re-
spond to the combination of IL-12 and IL-18, 1-wk Th2
cells were completely nonresponsive. This is probably due
to the absence of endogenous IL-12 and IFN-  in Th2-
priming experiments. Similar results have been reported
by others (7, 32). The ability of IL-4 to regulate IL-18–
induced IFN-  production was also evident in T cells from
Stat6 /  mice, which secreted significantly more IFN-  in
response to IL-18/IL-12 plus IL-18 when compared with
controls. This enhanced production of IFN-  correlated
with increased levels of IL-18R  expression. Although
IFN-  production in response to IL-18 appeared to corre-
late with expression of the IL-18R , we cannot exclude
the possibility that increased expression/induction of IL-
18R  accounted, in part, for enhanced IFN-  production
in response to IL-18. Very little information is available
concerning the regulation of IL-18R  expression (20).
Intriguingly, 1-wk Th null cells still responded vigor-
ously to the combination of IL-12 and IL-18 by producing
significant amounts of IFN- . These in vitro findings raise
a number of questions about the possible role of IL-12 and
IL-18 in inducing IFN-  production during the course of
an inflammatory response in vivo. As IL-12 and IL-18 may
be produced by different cell types under different condi-
tions, one possibility is that T cells primed in an IL-12 rich
environment will subsequently be able to respond by pro-
ducing IFN-  in response to either cytokine alone in the
absence of reactivation by their TCR. Although the in
vivo equivalent of our Th null cell population has not been
directly demonstrated, immunization of mice with autoan-
tigens under certain conditions results in a population of
primed T cells that only produce IL-2 and not Th1/Th2
cytokines (33–34). It is possible that when these cells are
exposed to IL-12 and IL-18 in a paracrine fashion during
the course of an infectious insult they would complete their
differentiation into pathogenic Th1 cells.
Apart from the known effects of IL-18 in synergizing
with IL-12 to drive Th1 responses, recent reports have
shown that IL-18 can induce Th2-type responses (i.e., IgE,
IL-4, IL-13) (12–15). One interpretation of these studies is
that IL-18 is a potent inducer of IL-4 and IL-13 production
by basophils and mast cells, or possibly CD4  T cells. In-
deed, induction of IL-4 production by IL-18 in NK T cells
has recently been reported (35), which is consistent with
our observation that unstimulated CD4  NKT cells express
high levels of IL-18R  similar to NK cells (data not
shown). Such a systemic production of IL-4 may facilitate
the priming of antigen-specific CD4  Th2 cells. Our ob-
servation that IL-4 leads to downregulation of the IL-
18R  on CD4  T cells is very compatible with such a
model, as the absence of the IL-18R  on the antigen-
responsive T cells would further prevent the potential co-
stimulatory effects of IL-18 on IL-12–mediated Th1 differ-
entiation. Since this IL-4–mediated downregulation of
IL-18R  was only observed when T cells were triggered
through the TCR, bystander effects of IL-4 on resting cells
that express the IL-18R  would not occur. Ultimately, the
major factor that determines whether IL-18 potentiates
Th1- or Th2-type immune responses is likely to be the bal-
ance between IL-12 and IL-4 in the microenvironment
during T cell priming. The presence of IL-12, as well as the
expression of IL-12 receptor components, would allow IL-
18 to synergize with IL-12 in the development of Th1 de-
velopment. Conversely, the presence of specialized cell
types capable of making IL-4 in response to IL-18 (i.e. mast
cells) would favor IL-18 as a potentiator of Th2 responses.
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